Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial
Top Cited Papers
- 1 April 2005
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 365 (9470), 1552-1560
- https://doi.org/10.1016/s0140-6736(05)66456-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Time course of recovery of health status following an infective exacerbation of chronic bronchitisThorax, 2003
- Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPDThorax, 2003
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbationsThorax, 2002
- The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and designEuropean Respiratory Journal, 2001
- Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: A meta-analysis of published double-blind, placebo-controlled clinical trialsClinical Therapeutics, 2000
- The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?European Respiratory Journal, 1994
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982